MOMENTUM
Recruiting
8,000 enrolled
Detecting HPV DNA in Anal and Cervical Cancers
Recruiting
20 enrolled
Low-Dose Radiotherapy to Sensitize Pucotenlimab Plus CAPEOX for pMMR Locally Advanced Rectal Cancer
Phase 2 Recruiting
50 enrolled
Study of Tislelizumab Combined With Chemoradiotherapy and Surgery for Unresectable Esophageal Squamous Cell Carcinoma
Phase 2 Recruiting
45 enrolled
FORTRESS
Phase 1 Recruiting
30 enrolled
CCRT Followed by PD-1 Inhibitor Maintenance Therapy in Locally Advanced ESCC
Phase 3 Recruiting
452 enrolled
LAP100
Phase 3 Recruiting
356 enrolled
Total Neoadjuvant Therapy With mFOLFOX and Short-course Radiation in Resectable Rectal Cancer
Phase 2 Recruiting
54 enrolled
LDRT Combined With Pucotenlimab and Standard Therapy for Advanced Pancreatic Cancer: A Single-Arm Study
Phase 1/2 Recruiting
10 enrolled
Chemoradiotherapy in Esophageal or Esophagogastric Junction Cancer
Phase 3 Recruiting
2,000 enrolled
SBRT Plus Systemic Therapy vs Systemic Therapy Alone in BCLC C Hepatocellular Carcinoma
Phase 2 Recruiting
184 enrolled
Surufatinib in Combination With Neoadjuvant Chemo-immunotherapy and Concurrent Chemoradiotherapy for Patients With Unresectable Locally Advanced Esophageal Squamous Cell Carcinoma
Phase 2 Recruiting
69 enrolled
NBTXR3 Activated by Radiation Therapy for the Treatment of Locally Advanced or Borderline-Resectable Pancreatic Cancer
Phase 1 Recruiting
24 enrolled
Chemotherapy With or Without Radiation or Surgery in Treating Participants With Oligometastatic Esophageal or Gastric Cancer
Phase 2 Recruiting
100 enrolled
Hypofractionated Radiotherapy Combined With NALIRIF, PD-1 Antibody in Locally Recurrent Rectal Cancer(NOVELTY-R)
Phase 2 Recruiting
44 enrolled
Neoadjuvant Radiotherapy Plus Tegafur, Oxaliplatin and Iparomlimab and Tuvonralimab in Resectable Gastric and GE-junction Cancer : A Randomized, Two-arm, Prospective Trial (TRIUNITE-05)
Phase 2 Recruiting
40 enrolled
Assessment of Efficacy and Safety of PD-1 Monoclonal Antibody Combined With IL-2 and CapeOX in Neoadjuvant Therapy for Locally Advanced Rectal Cancer Prior to Surgery: A Prospective, Multi-center, Randomized Controlled Study
Phase 2 Recruiting
130 enrolled
KANALRAD
Phase 3 Recruiting
310 enrolled
PANTHER
Phase 2 Recruiting
43 enrolled
Multi-omics Sequencing in Neoadjuvant Immunotherapy of Gastrointestinal Tumors
Phase 2 Recruiting
200 enrolled
PRORECT
Phase NA Recruiting
254 enrolled
PTCA199-7
Phase 2 Recruiting
30 enrolled
Continuation of First-line Therapy With Radiotherapy Versus Early Switch to Second-line Therapy in Oligoprogressive HCC
Phase 3 Recruiting
132 enrolled
JUMP
Phase NA Recruiting
86 enrolled
Papaverine in Combination With Radiation Therapy for the Treatment of Locally Advanced Rectal Cancer, DINOMITE Trial
Phase 1 Recruiting
36 enrolled
AGAMENON
Recruiting
10,000 enrolled
Radiotherapy + Systemic Therapy as Conversion Therapy for pMMR/MSS T4M0 Colon Cancer（Neo-Color）
Phase 2 Recruiting
128 enrolled
Fruquintinib Combined With Sintilimab ± Radiotherapy for Third-line Treatment of Colorectal Cancer With Liver Metastases
Phase 2 Recruiting
62 enrolled
FOLFOX, Botensilimab, and Balstilimab for the Treatment of Localized Rectal Cancer Before Surgery
Phase 2 Recruiting
26 enrolled
Personalized Long-course Radiotherapy Plus Chemotherapy With or Without Immunotherapy for LARC: PALACE Study
Phase 3 Recruiting
184 enrolled
Low-dose Radiation Combined With Neoadjuvant Immunochemotherapy for Esophageal Squamous Cell Carcinoma
Phase 2 Recruiting
30 enrolled
CORRECT
Phase NA Recruiting
110 enrolled
Tumor Local Excision +Postoperative Adjuvant Chemoradiotherapy for T1-2N0M0 Low/Ultra-Low Rectal Cancer
Phase 2 Recruiting
60 enrolled
Hypo-OPRA
Phase 2 Recruiting
35 enrolled
Nimotuzumab Plus Definite Chemoradiotherapy(dCRT) in Elderly Patients With Esophageal Squamous Cell Carcinoma
Phase 2 Recruiting
95 enrolled
LDRT Combined With Immunochemotherapy for Colorectal Cancer With Liver Metastasis
Phase 1 Recruiting
9 enrolled
Benmelstobart Combined With Radiochemotherapy as Neoadjuvant Treatment Iin ESCC
Phase 2 Recruiting
100 enrolled
ONTRESCC
Phase 2/3 Recruiting
120 enrolled
SAVIOR
Phase NA Recruiting
110 enrolled
Efficacy and Safety of Radiotherapy in Oligoprogressive HCC Following First-line PD-1 Therapy
Phase 2 Recruiting
35 enrolled
REGINA
Phase 2 Recruiting
72 enrolled
PREDIR-NEOREC
Phase 3 Recruiting
68 enrolled
ARO 2024-13
Phase NA Recruiting
264 enrolled
Low-dose Radiotherapy Combined With Chemotherapy and AK112 as Second-line Treatment in Patients With Advanced G/GEJ Cancer
Phase 2 Recruiting
45 enrolled
Total Neoadjuvant Therapy and Organ Preservation Versus Surgery for Rectal Cancer.
Phase 2/3 Recruiting
400 enrolled
Chemoradiotherapy in Unresectable Esophageal Cancer
Phase 1/2 Recruiting
105 enrolled
TNTRect
Recruiting
35 enrolled
A Phase II Clinical Study of Sintilimab Combined with Chemotherapy Followed by Concurrent Chemoradiotherapy for Locally Advanced Unresectable Esophageal Squamous Cell Carcinoma (ESCC) (NICE-CS)
Phase 2 Recruiting
52 enrolled
SJZ-RMEEC01
Phase 2 Recruiting
67 enrolled
Radiotherapy Delays Second-line Drug Therapy for Oligo Progressive Primary Liver Cancer
Recruiting
36 enrolled